AXOGEN INC. - COMMON STOCK

Axogen, Inc. Reports 2023 Third Quarter Financial Results

07 ноя 2023 06:00:01 Источник Nasdaq GlobeNewswire

Axogen, Inc. to Report Third Quarter 2023 Financial Results and Host Conference Call on November 7, 2023

18 окт 2023 06:00:00 Источник Nasdaq GlobeNewswire

Axogen to Participate at Upcoming Investor Conferences

31 авг 2023 06:00:00 Источник Nasdaq GlobeNewswire

Axogen, Inc. Begins Processing Avance® Nerve Graft at New State-of-the-Art Facility in Dayton, Ohio

21 авг 2023 06:00:00 Источник Nasdaq GlobeNewswire

Axogen, Inc. Reports 2023 Second Quarter Financial Results

07 авг 2023 15:01:10 Источник Nasdaq GlobeNewswire

Axogen to Participate at Canaccord Genuity’s 43rd Annual Growth Conference

27 июл 2023 06:00:01 Источник Nasdaq GlobeNewswire

Axogen, Inc. to report second quarter 2023 financial results and host conference call on August 7, 2023

26 июл 2023 06:00:01 Источник Nasdaq GlobeNewswire

Axogen to Participate at Jefferies Healthcare Conference

24 май 2023 06:00:00 Источник Nasdaq GlobeNewswire

Axogen to Participate at JMP Securities Life Sciences Conference

12 май 2023 06:00:00 Источник Nasdaq GlobeNewswire

Axogen, Inc. Reports 2023 First Quarter Financial Results

09 май 2023 06:00:03 Источник Nasdaq GlobeNewswire

Axogen, Inc. to report first quarter 2023 financial results and host conference call on May 9, 2023

18 апр 2023 15:05:00 Источник Nasdaq GlobeNewswire

Axogen, Inc Reports 2022 Fourth Quarter and Full-Year Financial Results

14 мар 2023 06:00:01 Источник Nasdaq GlobeNewswire

Axogen, Inc. Appoints Marc Began as Executive Vice President and General Counsel

06 мар 2023 06:00:00 Источник Nasdaq GlobeNewswire

Axogen, Inc. to report fourth quarter 2022 financial results and host conference call on March 14, 2023

02 мар 2023 15:00:00 Источник Nasdaq GlobeNewswire

Axogen, Inc. Appoints Jens Schroeder Kemp as Chief Marketing Officer

13 фев 2023 06:00:00 Источник Nasdaq GlobeNewswire

Axogen Reports Preliminary Unaudited Revenue for Fourth Quarter and Full-Year 2022

09 янв 2023 06:00:00 Источник Nasdaq GlobeNewswire

Axogen Announces Independent Publication of Comparative Nerve Gap Repair Meta-Analysis of 35 peer-reviewed studies of Allograft, Autograft, and Conduits

05 янв 2023 06:00:00 Источник Nasdaq GlobeNewswire

Axogen to Participate at J.P. Morgan 41st Annual Healthcare Conference

04 янв 2023 06:00:00 Источник Nasdaq GlobeNewswire

Axogen Patient to Ride the 2023 Donate Life Rose Parade® Float Supporting awareness of organ and tissue donation

19 дек 2022 06:00:00 Источник Nasdaq GlobeNewswire

Axogen, Inc Reports 2022 Third Quarter Financial Results

08 ноя 2022 06:00:02 Источник Nasdaq GlobeNewswire